Bleomycin hydrolase (BLMH) is a kind of drug‐metabolizing enzymes that were highly expressed in drug‐resistant colon cancer stem cells, but no previous studies was conducted to detect the prognostic role of BLMH in colon cancer (Emmink et al., 2013). The gene discussed is BLMH; the disease is colonic neoplasm.